Home › WorldZevra anticipates filing MIPLYFFA sNDA in Q1 2027 as CHMP opinion remains expected in Q42 articles from 1 source · updated November 4, 2026, 04:53 UTCCoverageZevra anticipates filing MIPLYFFA sNDA in Q1 2027 as CHMP opinion remains expected in Q4 Seeking Alpha · November 4, 2026, 04:46 UTCZevra Therapeutics Reports Q3 2026 Revenue of $37.8 Million and Updates MIPLYFFA Regulatory Timeline Seeking Alpha · November 4, 2026, 04:46 UTC